Viewing nowLinagliptin Tablet (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.

MFDS item code 201900150 · Approved 2019.01.11 · Insurance code 649105900
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in combination with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications. This effectively improves blood sugar management and helps maintain health.
The recommended dose of this medicine is 5mg once daily. It may be administered with or without food. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.
This medication should not be used in patients with allergies to the active ingredient or any other components, in patients with type 1 diabetes, or in those with diabetic ketoacidosis. Caution is needed when used in combination with insulin or sulfonylureas that can cause hypoglycemia, as the risk of hypoglycemia may increase. Especially in patients with severely impaired kidney function, the risk of hypoglycemia may increase when used with insulin, and dose adjustment may be necessary. Use of this medication is limited in patients with heart failure, so it should be used cautiously, and patients should stop using the medication and consult a physician if symptoms such as abdominal pain occur, as acute pancreatitis may develop. Additionally, a rare skin condition called bullous pemphigoid has been reported, so if blisters or sores occur on the skin, medical professionals should be informed immediately and the medication should be discontinued. Patients should regularly check blood sugar levels during use, as hypoglycemic symptoms may occur, and consult medical professionals in case of abnormal symptoms. Pregnant women or nursing mothers are advised to avoid this medication as its safety has not been established. It is not recommended for children under 10 years of age, as safety and efficacy have not been sufficiently validated. Elderly patients or those with impaired kidney and liver function can use it without special dose adjustments, but regular monitoring is necessary. In case of overdose, it is important to remove any unabsorbed medication from the gastrointestinal tract and observe symptoms while receiving necessary treatment. Finally, this medication should be stored out of reach of children, and it is safer and helps maintain quality not to transfer to another container.
hypoglycemia, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, constipation, oral ulcer formation, rash, vesicular pemphigoid, joint pain accompanied by severity and disability, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial swelling, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, decreased appetite, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, dizziness, sensory impairment, pruritus, insomnia, depression, hypertension, hearing loss, erectile dysfunction, goiter, anxiety, mood disorder, bruise, bone bruise, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, eye discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius, which helps to preserve the medication's effectiveness and ensure safe use.
Pale pink round film-coated tablet
28 tablets [14 tablets/PTPX2], 30 tablets [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin 5mg
Tablet · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.